Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by St��phane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France.

Part of The Mcclay Foundation, Almac Diagnostic Services Ltd. is a company headquartered in Craigavon, UK. The firm engages in development of cancer diagnostics.\nThe company says this about itself: Almac Diagnostics is a stratified medicine company specialising in biomarker driven clinical trials. The company, based in Craigavon, UK and Durham, USA has been in existence for over 15 years. Our diagnostic experience spans: Oncology, Immunology, CNS and Infective diseases.

Pro Pharm, Inc. operates as a pharmacy. The company is headquartered in Sainte-Marie, Canada.

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

Centre Hospitalier Universitaire Vaudois (doing business as Lausanne University Hospital) is a private company headquartered in Lausanne, Switzerland, that operates university hospitals.\nThe company says this about itself: The CHUV, Lausanne University Hospital, is one of the five university hospitals in Switzerland. With its 16 clinical and medico-technical departments and their numerous services, the CHUV is renowned for its academic achievements in health care, research, and teaching. The CHUV is also a well-known center of medical education and research thanks to its collaboration with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). The CHUV has been recognized as one of the World?s 10 best hospitals according to the 2021 ranking of Newsweek magazine. It is with enthusiasm, that the Chairman of the Department of Urology, Prof Beat Roth, will pursue and support the research and studies with this novel treatment for bladder cancer.

Nanopharm Ltd. engages in the provision of orally inhaled and nasal drug product design and development services. It offers pre-formulation, formulation, and analytical solutions. The company was founded by Robert Price and is headquartered in Newport, the United Kingdom.

SCIMED Life Systems is a Manufacturing company.

CASI Pharmaceuticals, Inc. ("CASI", "we" or "us") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. CASI is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. CASI is executing its plan to become a biopharmaceutical leader by launching medicines in the greater China market leveraging CASI's China-based regulatory and commercial competencies and its global drug development expertise.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Qingdao Marine Biomedical Research Institute Co., Ltd., established on 2013-07-26, Business scope includes licensed projects:Drug Wholesale;pharmaceutical production;Drug retail;Pharmaceutical commissioned production;Health food production;Health food sales;food production;food business(Selling prepackaged food);food business(sell bulk food);food business;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Sales of formula food for special medical purposes;Production of formula food for special medical purpose;Cosmetic production;Production of sterile equipment;Disinfection equipment sales;Inspection and testing service;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;New material technology research and development;New material technology promotion service;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products;Cosmetics Wholesale;Cosmetics Retail;Disinfectant sales(Free of Hazardous Chemicals);Extraction of marine bioactive substances,purification,Synthesis technology research and development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Offshore engineering design and module design and manufacturing services;Asset management services for self-owned capital investment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hangzhou Lesuo Pharmaceutical Co., Ltd., established on 2012-11-21, Business scope includes drug development,technical consulting,Serve,transfer;Research and development of biochemical products,Sales(Removal of hazardous chemicals and precursor chemicals)**

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

A leader in therapeutic antibodies, ImClone Systems (also called "the company") is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. Founded in 1984, ImClone has a rich culture of discovery and deep expertise in oncology. The company has utilized the many advances made in the fields of molecular biology, oncology, genomics, and antibody engineering to build a novel pipeline of product candidates designed to address specific genetic mechanisms involved in cancer growth and development. Beyond its blockbuster marketed product ERBITUX®, ImClone has several additional investigational monoclonal antibodies in various stages of clinical development. Following its acquisition by Eli Lilly and Company in 2008, ImClone Systems is accelerating its antibody pipeline development by leveraging Lilly's global capabilities. ImClone's pipeline has several molecules in mid- to late-stage clinical development targeting virtually all major solid tumor types. Additionally, ImClone plans to advance several additional targets from its research programs into clinical development over the coming years. ImClone's research and clinical development capabilities are augmented by its expertise in the scale-up and manufacturing of biologics. The company's state-of-the-art FDA-approved manufacturing facilities in Branchburg, New Jersey, provide it with one of the largest biologic manufacturing capacities in the world. ImClone's Branchburg campus also houses it clinical development and administration operations. The company's research headquarters are based in New York City and it has international operations in Europe.

Boryung Corp. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API. The company was founded on November 11, 1963 and is headquartered in Seoul, South Korea.

ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA.

Hangzhou Hunter Biotechnology Co., Ltd. is a private company headquartered in Hangzhou, China. The firm provides pharmaceutical products.

Qingdao Haisheng Yangrun Biotechnology Co., Ltd., established on 2011-11-23, The scope of business includes the development of marine biological products,Marine Biotechnology Consulting,Services and Transfers,Medical Technology Development,Technology research and development and technology transfer of new materials,R&D and sales of medical devices(Carry out business activities according to the license issued by the Food and Drug Administration),wholesale,retail:clothing,cosmetic,Office Supplies,Daily necessities,Production,wholesale:food(issued by the Food and Drug Administration<food production license>,<Food distribution license>Carry out business activities).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).